Self-guided treatment for patients with social anxiety disorder Mental and Behavioural Disorders
Conditions
Interventions
The study is a single-center randomized controlled trial. Relative changes in SAD symptoms (interim vs. baseline, post vs. baseline, follow-up vs. baseline) will be compared between a group receiving
Sponsors
University of Siegen
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Social anxiety disorder (F40.1)
Exclusion criteria
Exclusion criteria: 1. Stroke or coronary in the past 2. Angina pectoris 3. Cardiac arrhythmias 4. Hypertension 5. Asthma or a chronic obstructive pulmonary disease (COPD) 6. Pregnancy or the suspicion 7. Strong visual disorders 8. Epilepsy or seizures in the past 9. Psychological disorders with organic cause (for example dementia) 10. Vertigo 11. Vestibular impairments 12. Psychological or behavioral disorders because of the consumption of psychoactive substances 13. Schizophrenia, schizotypal or delusional disorders 14. Severe depression or mania 15. Acute suicidal tendencies or lack of capability to negotiate a no-suicide agreement 16. Not yet in therapy
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Questionnaire on social anxiety and social competence deficits (SASKO) measured on the second, third and fourth appointment | — |
Secondary
| Measure | Time frame |
|---|---|
| Remission, measured via Mini-DIPS at the baseline and follow-up assessment | — |
Countries
Germany
Outcome results
None listed